LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

Search

BeOne Medicines Ltd ADR

Chiusa

SettoreSettore sanitario

375.03 2.54

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

365.73

Massimo

384.76

Metriche Chiave

By Trading Economics

Entrata

31M

125M

Vendite

97M

1.4B

Margine di Profitto

8.84

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+6.9% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

22B

Apertura precedente

372.49

Chiusura precedente

375.03

BeOne Medicines Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 nov 2025, 12:16 UTC

I principali Market Mover

Zymeworks, Jazz Pharmaceuticals Shares Rise Following Positive Phase 3 Results for Cancer Treatment

12 mag 2025, 02:16 UTC

I principali Market Mover

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

29 gen 2025, 15:59 UTC

I principali Market Mover

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

27 nov 2024, 15:22 UTC

I principali Market Mover

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

21 nov 2024, 14:45 UTC

I principali Market Mover

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

6 nov 2025, 11:01 UTC

Utili

BeOne Medicines Sees FY25 Rev $5.1B-$5.3B >ONC

6 nov 2025, 11:01 UTC

Utili

BeOne Medicines 3Q Adj EPS $2.65 >ONC

6 nov 2025, 11:01 UTC

Utili

BeOne Medicines 3Q Rev $1.4B >ONC

6 nov 2025, 11:00 UTC

Utili

BeOne Medicines 3Q EPS $1.09 >ONC

6 ago 2025, 10:01 UTC

Utili

BeOne Medicines Narrows FY25 View To Rev $5.0B-$5.3B >ONC

6 ago 2025, 10:01 UTC

Utili

BeOne Medicines 2Q Rev $1.3B >ONC

6 ago 2025, 10:01 UTC

Utili

BeOne Medicines 2Q Adj EPS $2.25 >ONC

6 ago 2025, 10:00 UTC

Utili

BeOne Medicines 2Q EPS 84c >ONC

9 lug 2025, 09:17 UTC

Azioni calde

Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ

7 mag 2025, 10:07 UTC

Utili

BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC

7 mag 2025, 10:06 UTC

Utili

BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC

7 mag 2025, 10:05 UTC

Utili

BeiGene 1Q Net $1.27M >ONC

7 mag 2025, 10:04 UTC

Utili

BeiGene Says to Rename Company to BeOne Medicines >ONC

7 mag 2025, 10:02 UTC

Utili

BeiGene 1Q EPS $0.00 >ONC

7 mag 2025, 10:02 UTC

Utili

BeiGene 1Q Rev Increased 49% >ONC

7 mag 2025, 10:00 UTC

Utili

BeiGene 1Q Rev $1.12B >ONC

27 feb 2025, 11:07 UTC

Utili

BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC

27 feb 2025, 11:06 UTC

Utili

BeiGene 4Q Global BRUKINSA Rev of $828M >ONC

27 feb 2025, 11:06 UTC

Utili

BeiGene 4Q Loss/Shr 11c >ONC

27 feb 2025, 11:06 UTC

Utili

BeiGene 4Q Rev $1.13B >ONC

Confronto tra pari

Modifica del prezzo

BeOne Medicines Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

6.9% in crescita

Previsioni per 12 mesi

Media 391.06 USD  6.9%

Alto 424 USD

Basso 362 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per BeOne Medicines Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

11 ratings

10

Acquista

1

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Utile operativo

$

Chi Siamo BeOne Medicines Ltd ADR

BeiGene Ltd
help-icon Live chat